Azilsartan suppresses the antiapoptotic biomarker and pro-inflammatory cytokines in rat model of cisplatin-induced retinal and optic nerve toxicity
Human & Experimental Toxicology · 2023-03 · 42
DOI: 10.1177/09603271231155092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human & Experimental Toxicology, online erschienen am 17.03.2023. Verfasst von Noor Majid Raheem und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, 275719University of Sulaimani, Sulaimaniyah, Iraq. Hauptthemen laut MEDLINE: Cisplatin, Cytokines. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The local renin-angiotensin system has been discovered in the eyes; thus, this study evaluates the Azilsartan effect in the retina and optic nerve toxicity induced by Cisplatin in vivo. Methodology Forty-eight male rats were randomly assigned into six groups of 8 animals. Group 1 was healthy control that received 0.5 mL/day of 0.5% carboxymethyl cellulose (CMC) orally (PO). Group 2 received a single dose of the 7.0 mg/kg CIS intraperitoneally with 0.5 mL/day of 0.5% CMC-PO. Groups 3 and 4 received 3.5 and 7.0 mg/kg/day of AZIL-PO, respectively. Groups 5 and 6 received 3.5 and 7.0 mg/kg/day of AZIL-PO, respectively together with a single dose of 7.0 mg/kg of CIS-IP. The ocular tissue and serum estimated the TNF-α, NF-kβ, and Casp-3. A complete blood count was also measured, and the eye was sent for histological examination.
Results
The administration of the 3.5 mg/kg AZIL significantly ( p < 0.05) reduced the ocular tissue and serum TNF-α, NF-kB, and Casp-3 levels, when given to CIS treated group, while the 7.0 mg/kg AZIL does not. Additionally, azilsartan shows no negative impact on the CBC in rats. Finally, the eye histological examination showed a significant ( p < 0.05) drop in the signs of inflammation and cellular degeneration, particularly after administration of the 3.5 mg/kg AZIL to the CIS-treated group.
Conclusion
A low dose of AZIL exerts an anti-inflammation and an anti-apoptotic effect through significant suppression of the pro-inflammatory mediators and an apoptotic biomarker by blocking the local angiotensin II type
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Pharmacy, 275719University of Sulaimani, Sulaimaniyah, Iraq.
ORCID-Profile: Naza Mohammed Ali Mahmood
Zitieren
APA
Raheem, N. M., & Mohammed Ali Mahmood, N. (2023). Azilsartan suppresses the antiapoptotic biomarker and pro-inflammatory cytokines in rat model of cisplatin-induced retinal and optic nerve toxicity. Human & Experimental Toxicology, 42. https://doi.org/10.1177/09603271231155092
Vancouver
Raheem NM, Mohammed Ali Mahmood N. Azilsartan suppresses the antiapoptotic biomarker and pro-inflammatory cytokines in rat model of cisplatin-induced retinal and optic nerve toxicity. Human & Experimental Toxicology. 2023;42. doi:10.1177/09603271231155092
BibTeX
@article{Raheem2023,
author = {Raheem, Noor Majid and Mohammed Ali Mahmood, Naza},
title = {Azilsartan suppresses the antiapoptotic biomarker and pro-inflammatory cytokines in rat model of cisplatin-induced retinal and optic nerve toxicity},
journal = {Human & Experimental Toxicology},
year = {2023},
volume = {42},
doi = {10.1177/09603271231155092}
}
EUVIMED